Elbit Real Estate Ltd. logo

Elbit Real Estate Ltd. (ELRL)

Market Open
7 Aug, 15:25
TASE TASE
419. 60
ILA
+9.1
+2.2168%
ILA
- Market Cap
- P/E Ratio
- Div Yield
848 Volume
- Eps
410.5 ILA
Previous Close
Add Transaction
Day Range
406 440
Year Range
400 750
Want to track ELRL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ELRL trading today higher at 419.6 ILA, an increase of 2.2168% from yesterday's close, completing a monthly decrease of -3.8497% or -16.8 ILA. Over the past 12 months, ELRL stock lost -14.6981%.
ELRL is not paying dividends to its shareholders.
Elbit Real Estate Ltd. has completed 2 stock splits, with the recent split occurring on Jun 26, 2016.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TASE (ILA).

ELRL Chart

Elbit Real Estate Ltd. (ELRL) FAQ

What is the stock price today?

The current price is 419.60 ILA.

On which exchange is it traded?

Elbit Real Estate Ltd. is listed on TASE.

What is its stock symbol?

The ticker symbol is ELRL.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Elbit Real Estate Ltd. ever had a stock split?

Elbit Real Estate Ltd. had 2 splits and the recent split was on Jun 26, 2016.

Elbit Real Estate Ltd. Profile

Real Estate Management & Development Industry
Real Estate Sector
Eran Mazor CEO
TASE Exchange
- ISIN
IL Country
3 Employees
- Last Dividend
26 Jun 2016 Last Split
- IPO Date

Overview

Elbit Imaging Ltd., based in Petah Tikva, Israel, operates globally, engaging in the development, production, and marketing of therapeutic medical systems for non-invasive treatments. Originally founded in 1996 as Elbit Medical Imaging Ltd., the company underwent a name change in November 2007 to better reflect its diverse offerings. Its journey from focusing primarily on medical imaging solutions to a broader therapeutic portfolio demonstrates its evolution within the healthcare and real estate industries. The company's international presence is underscored by its involvement in both the healthcare sector, with innovative medical solutions, and the real estate sector, through the sale of plots and villas in India.

Products and Services

  • Treatment-oriented Medical Systems

    The core of Elbit Imaging's healthcare solutions, these medical systems utilize ultrasound beams and magnetic resonance imaging (MRI) technology. Aimed at non-invasive treatments, these systems are designed to offer therapeutic interventions without the need for surgical procedures, thereby reducing patient recovery time and improving overall treatment outcomes.

  • Stem Cell-Based Medical Products

    Capitalizing on the regenerative potential of stem cells, Elbit Imaging offers medical products derived principally from umbilical cord blood. These products are intended for critical applications such as bone marrow transplantation in patients suffering from severe conditions like leukemia, lymph node cancer, non-malignant blood diseases, and metabolic genetic diseases. The stem cell-based products signify the company's commitment to pioneering in the field of regenerative medicine, providing new hope for patients with previously untreatable conditions.

  • Real Estate in India

    Expanding beyond its medical technology footprint, Elbit Imaging also ventures into the real estate market in India. The company's involvement includes the sale of plots and villas, tapping into the growing demand for quality housing and investment properties in one of the world's fastest-growing economies. This diversification exemplifies Elbit Imaging's strategy to explore new business opportunities and revenue streams outside its core focus, leveraging its expertise and reputation for delivering high-value projects.

Contact Information

Address: 3 Shimson Street
Phone: 972 3 608 6000